Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott A Tomlins

Showing results (51-60 of 231) with videos related to

Pageof 24
Sort By:
Neoplasia (New York, N.Y.)|November 19, 2004
Expression of the platelet-derived growth factor receptor in prostate cancer and treatment implications with tyrosine kinase inhibitorsMatthias D Hofer, Alice Fecko, Ronglai Shen, et al.
The Journal of Clinical Endocrinology and Metabolism|January 15, 2016
Molecular Heterogeneity in Aldosterone-Producing AdenomasKazutaka Nanba, Andrew X Chen, Kei Omata, et al.
The Prostate|May 7, 2014
Identification of a novel germline SPOP mutation in a family with hereditary prostate cancerKimberly A Zuhlke, Anna M Johnson, Scott A Tomlins, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|September 30, 2014
Determination of Optimum Formalin Fixation Duration for Prostate Needle Biopsies for Immunohistochemistry and Quantum Dot FISH AnalysisUbaradka G Sathyanarayana, Chandler Birch, Raymond B Nagle, et al.
Journal of Hematology & Oncology|October 8, 2015
Comprehensive serial molecular profiling of an "N of 1" exceptional non-responder with metastatic prostate cancer progressing to small cell carcinoma on treatmentKunal C Kadakia, Scott A Tomlins, Saagar K Sanghvi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 9, 2016
Clonal evaluation of prostate cancer foci in biopsies with discontinuous tumor involvement by dual ERG/SPINK1 immunohistochemistryJacqueline Fontugne, Kristina Davis, Nallasivam Palanisamy, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 2, 2009
Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progressionBo Han, Rohit Mehra, Robert J Lonigro, et al.
The Prostate|July 22, 2014
Frequent discordance between ERG gene rearrangement and ERG protein expression in a rapid autopsy cohort of patients with lethal, metastatic, castration-resistant prostate cancerAaron M Udager, Yang Shi, Scott A Tomlins, et al.
Cancer Research|August 29, 2012
CD24 is an effector of HIF-1-driven primary tumor growth and metastasisShibu Thomas, Michael A Harding, Steven C Smith, et al.
The American Journal of Surgical Pathology|April 12, 2014
HOXB13 G84E-related familial prostate cancers: a clinical, histologic, and molecular surveySteven C Smith, Nallasivam Palanisamy, Kimberly A Zuhlke, et al.
Pageof 24

Showing results (51-60 of 231) with videos related to

Sort By:
Pageof 24
Neoplasia (New York, N.Y.)|November 19, 2004
Expression of the platelet-derived growth factor receptor in prostate cancer and treatment implications with tyrosine kinase inhibitorsMatthias D Hofer, Alice Fecko, Ronglai Shen, et al.
The Journal of Clinical Endocrinology and Metabolism|January 15, 2016
Molecular Heterogeneity in Aldosterone-Producing AdenomasKazutaka Nanba, Andrew X Chen, Kei Omata, et al.
The Prostate|May 7, 2014
Identification of a novel germline SPOP mutation in a family with hereditary prostate cancerKimberly A Zuhlke, Anna M Johnson, Scott A Tomlins, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|September 30, 2014
Determination of Optimum Formalin Fixation Duration for Prostate Needle Biopsies for Immunohistochemistry and Quantum Dot FISH AnalysisUbaradka G Sathyanarayana, Chandler Birch, Raymond B Nagle, et al.
Journal of Hematology & Oncology|October 8, 2015
Comprehensive serial molecular profiling of an "N of 1" exceptional non-responder with metastatic prostate cancer progressing to small cell carcinoma on treatmentKunal C Kadakia, Scott A Tomlins, Saagar K Sanghvi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 9, 2016
Clonal evaluation of prostate cancer foci in biopsies with discontinuous tumor involvement by dual ERG/SPINK1 immunohistochemistryJacqueline Fontugne, Kristina Davis, Nallasivam Palanisamy, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 2, 2009
Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progressionBo Han, Rohit Mehra, Robert J Lonigro, et al.
The Prostate|July 22, 2014
Frequent discordance between ERG gene rearrangement and ERG protein expression in a rapid autopsy cohort of patients with lethal, metastatic, castration-resistant prostate cancerAaron M Udager, Yang Shi, Scott A Tomlins, et al.
Cancer Research|August 29, 2012
CD24 is an effector of HIF-1-driven primary tumor growth and metastasisShibu Thomas, Michael A Harding, Steven C Smith, et al.
The American Journal of Surgical Pathology|April 12, 2014
HOXB13 G84E-related familial prostate cancers: a clinical, histologic, and molecular surveySteven C Smith, Nallasivam Palanisamy, Kimberly A Zuhlke, et al.
Pageof 24